Selegiline HC1: Selective MAO-type B inhibitor.
Koller
W C
WC
Department of Neurology, University of Kansas Medical Center, Kansas City 66103.
Giron
L T
LT
D004334:Drug Administration Schedule; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D012642:Selegiline / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D008996:Monoamine Oxidase Inhibitors; D012642:Selegiline